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ABSTRACT 
 
Non-viral gene complexes can enter mammalian cells through different endocytic pathways. 
For efficient optimization of the gene carrier it is important to profile its cellular uptake, since this 
largely determines its intracellular processing and subsequent transfection efficiency. Most of the 
current information on uptake of these gene delivery vehicles is based on data following the use of 
chemical inhibitors of endocytic pathways. Here, we have performed a detailed characterization of 
four commonly used endocytic inhibitors (chlorpromazine, genistein, MßCD and potassium 
depletion) on cell viability and endocytosis in five well described cell lines. We found that 
chlorpromazine and to a lesser extent MßCD significantly decreased cell viability of some cell lines 
even after short incubation periods and at concentrations that are routinely used to inhibit 
endocytosis. Through analyzing the uptake and subcellular distribution of two fluorescent 
endocytic probes transferrin and lactosylceramide that are reported to enter cells via clathrin 
dependent and independent mechanisms respectively, we showed poor specificity of these agents 
for inhibiting distinct endocytic pathways. Finally we demonstrate that any inhibitory effects are 
highly cell line dependent. Overall the data questions the significance of performing endocytosis 
studies with these agents in the absence of very stringent controls. 
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INTRODUCTION 
 
Successful gene delivery relies on the development of non-toxic gene carriers or vectors that 
efficiently deliver foreign genetic material into target cells. Although viral vectors are quite 
effective, their clinical use is limited and this is mainly due to safety issues. As a safe(r) alternative, 
non-viral gene carriers, such as cationic liposomes or polymers, can be used. However, their low 
transfection efficiency is a major limiting factor. Because the cellular processing of the gene 
complexes strongly influences the efficiency of the carrier, a thorough mechanistic understanding 
of the pathways involved in the cellular uptake of these non-viral gene complexes may therefore 
help to design more effective gene carriers.  
The majority of reports on cellular uptake mechanisms suggests that endocytosis is the 
preferred route of cell entry of non-viral gene carriers [1]. As shown in Fig. S1, endocytosis can be 
classified in two broad categories: phagocytosis and pinocytosis [2]. Phagocytosis is typically 
restricted to specialized cells whereas pinocytosis occurs in all cell types. The study of different 
pinocytotic pathways is still an evolving field and no current classification system is completely 
satisfactory. Currently, pinocytosis is subdivided into macropinocytosis, clathrin dependent (CDE) 
and clathrin independent (CIE) endocytosis. During macropinocytosis, membrane protrusions, 
often called ruffles, are formed which can subsequently fuse with each other or with the plasma 
membrane to enclose large volumes [3]. Macropinocytosis is a non-selective endocytic mechanism 
for internalizing suspended macromolecules and the internalized vesicles or macropinosomes can 
have sizes up to 5 µm [4]. CDE is the best characterized endocytic pathway and is said to be the 
preferred pathway for microspheres up to 200 nm in size [5]. Certain macromolecules 
preferentially associate with this pathway and are specifically taken up in clathrin-coated vesicles. 
Examples are the Low Density Lipoprotein (LDL) receptor, the transferrin receptor and the 
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Epidermal Growth Factor (EGF) receptor. Human transferrin (hTF) is considered to be a good 
specific marker for CDE, as in its iron bound form it binds to the transferrin receptor and is taken 
up via CDE [6,7]. Although the details of the CIE mechanism have not been completely elucidated, 
its current sub-classification is based on the role of dynamin and several small GTPases [8]. These 
include uptake from lipid rafts in caveolae or via a flotillin dependent pathway. Rafts represent 
liquid ordered environments present in biological membranes enriched in unsaturated 
phospholipids, cholesterol, glycosphingolipids and certain proteins [9]. Caveolae mediated 
endocytosis is probably the best characterized CIE pathway. Caveolae are small (50-80 nm), 
smooth, flask-shaped invaginations of the plasma membrane that are characterized by the presence 
of caveolin-1 [10]. Certain pathogens, like SV40 virus and Cholera toxin subunit B (CTB) 
specifically use this pathway to enter cells and the latter is often used as a marker for this pathway 
[10,11]. However, a significant fraction of CTB is also taken up in clathrin-coated vesicles [12]. An 
alternative marker for CIE is lactosylceramide (LacCer), a glycosphingolipid that resides preferably 
in lipid rafts and the uptake from which is clathrin independent but dependent on dynamin and 
caveolin-1 [13-15]. LacCer has previously been used as a marker for caveolae mediated 
endocytosis [5,16]. Nonetheless, because there is evidence that caveolin-1 is not necessary for 
endocytosis of LacCer, we preferably define LacCer as a marker for clathrin independent 
endocytosis. Flotillin dependent endocytosis was recently characterized as a dynamin-2, caveolin-1 
and clathrin independent pathway [17]. Most cells also have the capacity to constitutively 
internalise fluid via less well characterised pathways and it is likely that other pathways remain to 
be discovered and characterized. 
A number of endocytic pathways have been demonstrated to be involved in the uptake of 
DNA complexes [18-21], and this is highly dependent on cell type [22,23], the nature of the gene 
carrier [24,25] and the particle size [5]. This variability stresses the necessity of studying the 
6 
internalization of each of the different types of non-viral gene carriers in an appropriate cell line 
model. A quantitative assessment of the contribution of each endocytic pathway to the overall 
cellular uptake is essential for elucidating the corresponding intracellular pharmacokinetic models. 
Specifically this may allow one to relate the endocytic pathway of a gene complex to its subsequent 
intracellular processing and transfection efficiency [26]. Much of the data on the cellular uptake of 
gene delivery vectors comes from studies using chemical inhibitors of endocytosis. A number of 
these are deemed to be specific for some of the described pathways but an increasing volume of 
evidence suggests that they lack specificity and may give misleading results [27]. While there are 
several tools available for elucidating the endocytic pathways involved in the uptake of gene 
complexes, the present paper focuses on the use of these inhibitors which can interfere with the 
endocytic processes. 
In this study, chlorpromazine and K+-depletion are evaluated as inhibitors of CDE. 
Chlorpromazine is a cationic amphiphilic drug which is believed to inhibit clathrin coated pit 
formation by a reversible translocation of clathrin and its adapter proteins from the plasma 
membrane to intracellular vesicles [28]. Potassium depletion is said to inhibit the formation of 
clathrin coated pits by dissociating the clathrin lattices at the inner leaflet of the plasma membrane 
[29]. Methyl-ß-cyclodextrin (MßCD) and genistein are evaluated as inhibitors of CIE. MßCD is a 
cyclic oligomer of glucopyranoside that inhibits cholesterol dependent endocytic processes by 
reversibly extracting the steroid out of the plasma membrane [30]. MßCD is regularly used to 
determine whether endocytosis is dependent on the integrity of lipid rafts. Genistein is a tyrosine-
kinase inhibitor and this agent causes local disruption of the actin network at the site of endocytosis 
and inhibits the recruitment of dynamin II, both known to be indispensible events in the caveolae 
mediated uptake mechanism [31,32]. Here, we evaluate the usefulness of these four well 
characterised inhibitors of endocytosis in 5 different cell lines. We initially investigate the 
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cytotoxicity of each of the inhibitors and subsequently, by using a combination of flow cytometry 
and confocal fluorescence microscopy, we evaluate the capacity and specificity of the agents to 
interfere with the uptake of endocytic markers. As endocytic markers we utilised two well 
characterised probes: human transferrin (hTf) for CDE and lactosylceramide (LacCer) for CIE. 
Overall, our data suggest that extreme care should be taken when interpreting data obtained from 
the use of these agents and we discuss these implications on drug delivery studies. 
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RESULTS 
 
Cytotoxicity of endocytosis inhibitors is cell type dependent 
 
To establish an optimal protocol for the use of endocytosis inhibitors for a specific cell type, 
it is imperative to evaluate their in vitro cellular toxicity. We investigated the viability of five 
different cell lines, HuH-7, Vero, COS-7, ARPE-19 and D407, after exposure to four frequently 
used inhibitors: chlorpromazine, K+-depletion, genistein and MßCD. Different concentrations of 
each inhibitor were tested on all cell lines and cellular toxicity was subsequently assessed with the 
MTT based EZ4U test. The inhibitor was in all cases diluted in OptiMEM and incubated with the 
cells for 2 h. In case of K+
Unlike HuH-7, ARPE-19 and D407 cells that were relatively insensitive to < 10 µg/ml 
chlorpromazine, COS-7 and Vero cells, both African green monkey kidney cells, were found to be 
sensitive to this agent (Fig. 1a). All cell lines retained >85% viability upon K
-depletion, cytotoxicity was determined following treatment with the 
different buffers as described in Materials and Methods. As positive and negative controls, cells 
were exposed for 2 h to 20 mg/ml phenol solution in OptiMEM and in OptiMEM alone, 
respectively. Cytotoxicity, expressed as a percentage of cell viability, was calculated from the 
measured absorbance values normalized to the negative control (100% viability) and taking into 
account the correction for the positive control (0% viability). Each experiment was carried out in 
quadruplicate, the results of which are shown in Fig. 1. 
+-depletion (Fig. 1b). 
MßCD exhibited only very slight cytotoxicity to ARPE-19, D407 and COS-7 cells at 10 mM, while 
Vero and especially HuH-7 cells were clearly more sensitive to the effects of this agent (Fig. 1c). 
Finally, none of the tested genistein concentrations had a noticeable effect on the viability of the 
five cell lines tested (Fig. 1d). Based on these results we conclude that some of these cell lines do 
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show significant toxicity after treatment with some of these inhibitors at concentrations that are 
routinely used for endocytosis studies.  
 
Selection of suitable inhibitor concentrations based on confocal microscopy and cytotoxicity data 
 
In addition to the cytotoxicity data, which define the upper concentration limit for a 
particular inhibitor and a particular cell line, we also evaluated the effect of the inhibitors at 
different concentrations in order to find the lower concentration limit at which the inhibitor is still 
active. In this way, we determined suitable concentrations of these agents allowing sufficient 
inhibition of specific endocytic pathways with acceptable toxicity. We evaluated by confocal 
microscopy the remaining internalization of two fluorescently labeled endocytic markers, hTF and 
LacCer, that are known to be specifically internalised by CDE and CIE respectively, after 
incubation with different inhibitor concentrations. K+-depletion and chlorpromazine are reported to 
specifically inhibit CDE, whilst MßCD and genistein have been extensively used to inhibit CIE. As 
an example, the effect of D407 cell exposure to different incubation times and concentrations of 
MßCD on LacCer uptake is shown in Fig. 2. Fig. 2a shows control cells after incubation with 
LacCer for 15 min and the probe is shown to label the plasma membrane and intracellular vesicles 
in the perinuclear region. Incubating the cells with MßCD prior to LacCer addition significantly 
reduced its uptake in a time and concentration dependent manner (Fig. 2b-f). However, longer 
incubation times (> 2 h) and higher concentrations (> 5 mM) had major morphological effects and 
the cells tended to detach from the growing surface during the experimental procedure. Fig. 2f 
already shows that MßCD can have pronounced effects on the cellular morphology. Like MßCD, 
other inhibitors also induce strong effects on cellular morphology, which could also be observed 
from flow cytometry analysis. Based on the flow cytometry scatter plot, one can observe for 
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example that treatment with chlorpromazine has strong effects on the ratio of forward scatter and 
side scatter of Vero cells (Fig. 3). We see a shift in the scatter profile to cells which exhibit more 
side scatter (Fig. 3b). The shift becomes even larger after LacCer and Back exchange treatment 
(Fig. 3c). This indicates a marked effect of the inhibitor treatment on cell morphology. However, 
after an additional PI staining, it seemed that only 1,2% extra dead cells were measured after 
chlorpromazine treatment and even less after chlorpromazine and back exchange (Fig. 3). The dead 
cells are probably all lost during the washing steps prior to FC analysis. Slight morphological 
effects were also observed after K+-depletion (not shown here). Based on the images in Fig. 2 and 
the toxicity data (Fig. 1) we determined that 2 h incubation with 5 mM MßCD was the preferential 
condition for subsequent analysis in case of the D407 cells. By performing similar endocytic 
marker uptake experiments for each endocytic inhibitor and each cell line, we have finally found 
the following optimal inhibitor conditions: 5 µg/ml chlorpromazine for 2 h for Vero and COS-7 
cells, 10 µg/ml chlorpromazine for 2 h for ARPE-19, D407 and HuH-7 cells, 400 µM genistein for 
2 h, 5 mM MßCD for 2 h and 15 min incubation with hypotonic buffer between the washing steps 
with K+-free buffer for K+
 
-depletion. 
Efficacy of endocytosis inhibitors is cell type dependent  
 
Having determined suitable inhibitor conditions, the efficacy of the CDE and CIE inhibitors 
to inhibit the uptake of respectively hTf and LacCer was assessed quantitatively in the different cell 
lines by flow cytometry. As can be seen in Fig. 4a, chlorpromazine treatment inhibited the uptake 
of hTf by approximately 50% in D407 and HuH-7 cells, but showed no or little significant 
inhibitory capacity in ARPE-19 and Vero cells and even an enhanced effect in COS-7 cells. While 
potassium depletion reduced hTF uptake by >80% in the D407 and HuH-7 cells, it had no 
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considerable effect on the COS-7 cells and even enhanced hTf uptake in the ARPE-19 and Vero 
cells. Pronounced differences between cell lines were also found when studying the inhibition of 
CIE, as can be seen in Fig. 4b. In general, both genistein and MßCD reduced LacCer uptake. We 
note that, while MßCD effectively inhibited LacCer uptake (> 60% inhibition) in all cell lines, post 
incubation treatments including back exchange and trypsinisation often reduced the number of cells 
that were available for subsequent analysis because cells started to detach during MßCD treatment 
(see also Fig. 2f). In the study of Rodal et al and in other examples [30,33], MßCD was used in 
combination with an inhibitor of cholesterol biosynthesis lovastatin. We therefore performed the 
same experiments where the preincubation periods were performed in the presence of both MßCD 
and lovastatin. The same inhibitory effects on endocytosis were observed as we did in cells treated 
with MßCD alone (Data not shown).  
The flow cytometry data was visually confirmed by confocal microscopy. Images in Fig. 5 
show the cell type dependency of genistein on the cellular uptake of LacCer. From left to right, the 
confocal images show an increase in inhibition of LacCer internalization (Fig. 5f-j). At this 
instance we would like to point out that care should be taken when evaluating inhibitory effects 
based on microscopy images alone. As is clear from the fluorescence histograms in Fig. 6, obtained 
by flow cytometry, the inhibitory effect is quite heterogeneous. The broad distributions indicate 
that, within the same cell population, some cells will be strongly inhibited, while others will not 
show any inhibition at all. Since microscopy images only show a very limited number of cells 
(typically tens of cells), we would like to suggest that they rather should be used as qualitative 
complementary data when studying cellular uptake to the flow cytometry data where tens of 
thousands of cells are analyzed quantitatively. 
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Lack of specificity of endocytosis inhibitors.  
 
Finally, we evaluated the specificity of the inhibitors for a particular endocytic pathway. 
The specificity of K+-depletion and chlorpromazine for inhibiting CDE was tested by looking at 
their effects on the uptake of LacCer. Similarly, the specificity of genistein and MßCD for 
inhibiting CIE was evaluated via studying the uptake of hTf. Chlorpromazine treatment had no 
inhibitory effect on LacCer uptake (Fig. 7a) and even caused a marked increase of the 
internalization of this marker in ARPE-19 and HuH-7 cells. In strong contrast to chlorpromazine, 
but equally surprising, we found that K+-depletion also inhibited CIE of ARPE-19, D407 and COS-
7 cells. Potassium depletion had no significant effect on CIE of Vero cells and slightly reduced 
LacCer uptake in HuH-7 cells. With the exception of D407 cells, genistein had little effect on hTf 
uptake in these cell lines. MßCD at the other hand, was highly effective at inhibiting this probe in 
all cell lines, which points out the lack of specificity of MßCD treatment. Again, these results were 
supported by confocal microscopy data. Fig. 8 shows that K+-depletion has a contrasting effect in 
both RPE cell lines: while the hTF internalization is completely inhibited in D407 cells, a 
considerable increase could be observed in ARPE-19 cells, in accordance with the flow cytometry 
data shown in Fig. 4a. The uptake of LacCer after this K+
 
-depletion is strongly reduced in D407 
cells and even more pronounced in ARPE-19 cells, again in agreement with the flow cytometry 
data (Fig. 7a). 
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DISCUSSION 
 
A thorough understanding of the intracellular pharmacokinetics and fate of a gene carrier 
complex, which is in part determined by the endocytic pathways through which they are 
internalized, is of great importance for optimal design of effective non-viral gene delivery carriers. 
Quantitative insight into the contribution of different endocytic pathways to the cellular uptake of 
carriers can be very helpful to achieve this goal since it will allow correlation of the effects of 
specific carrier characteristics with cellular uptake, intracellular processing and subsequent gene 
expression. The internalization and post-endocytic trafficking of gene carrier complexes can be 
studied by different approaches but all have their limitations. A common approach is to use 
inhibitors that are deemed to affect specific cellular uptake mechanisms. Transient or stable knock 
out mutants of proteins required for specific pathways can also be used as biological inhibitors. 
Transient knock outs can be created by using the RNA interference (RNAi) silencing mechanism or 
by introducing dominant negative proteins, resulting in silencing of crucial genes or inactivation of 
specific proteins respectively and subsequent inhibition of specific pathways [8,34-41].
Here, we have focused on the use of chemical inhibitors [42] to investigate their capacity to 
selectively block different endocytic pathways. The selected inhibitors are often used to study 
endocytic pathways, and in part this is because they are easy to use. When we first started using 
these agents, however, we found their specificity to be rather questionable, an issue which was 
recently brought up by others as well [27]. This led us to design a series of experiments to test a 
number of parameters that would dictate their usefulness for these kinds of studies. We initially 
discovered that some inhibitors showed clear morphological effects and toxicity even with short 
incubation times. There was also a huge variation in the efficacy of the selected inhibitors in the 
different cell lines. Additionally, they generally lacked specificity for defined pathways. It is 
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therefore important to fully characterize their effects on any particular cell line before attempting to 
define the uptake pathway for any particular macromolecule or nanoparticle that is deemed to enter 
cells by endocytosis. In the literature only a few examples exist whereby the non specific effects of 
these agents were evaluated [22,39,43,44]. 
Initially we showed that several of the tested inhibitors exhibit cell type dependent cytotoxic 
effects. For example, high chlorpromazine concentrations had little effect on the ARPE-19 and 
D407 cell viability, while all other tested cell lines, especially the COS-7 cells, were very sensitive 
to this agent. Similarly, MßCD showed cell specific cytotoxicity at high concentrations that are 
routinely used for these kinds of studies. These cytotoxic effects complicate data interpretation as 
the possibility exists that the cells will not survive the combined stress of inhibitor treatment and 
application of potentially cytotoxic cationic gene complexes. Additionally, in several cases we 
observed morphological changes of the cells after incubation with e.g. MßCD while the MTT test 
did not show any cytotoxic effects. This observation is in agreement with what has been reported 
before, namely that the sensitivity of the MTT assay depends on the mechanism by which the agent 
is affecting the cells [45]. Moreover, other side effects of inhibitors have been reported, such as 
effects on post-endocytic trafficking of gene carrier complexes [16]; thus they may affect initial 
uptake but also downstream pathways. It is therefore clear that all knowledge on the effects of 
inhibitors on cells will help leading to reliable interpretations and conclusions drawn following 
their use.  
Some of the results obtained were very unexpected and highlighted the different 
sensitivities of cell lines for individual inhibitors or treatments. Potassium depletion as expected 
inhibited the uptake of hTf in D407 and HuH-7 cells but was totally ineffective in other cell lines 
and even showed evidence of promoting uptake. Potassium depletion also proved to be a very 
effective inhibitor of LacCer uptake in four of the five tested cell lines suggesting that a fraction of 
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LacCer is internalised via CDE in these cells or more likely that potassium depletion affects a 
number of endocytic pathways. The inhibitory effect of K+-depletion on LacCer uptake has not 
previously been reported, neither has the underlying mechanism by which potassium depletion 
inhibits CIE been elucidated. The inhibitory effects of MßCD on transferrin uptake has previously 
been demonstrated [30,46] and we further demonstrate here that inhibition by this compound is not 
always a sign that uptake is directed via a clathrin independent route. In our experiments, 
chlorpromazine showed some degree of specificity, but in some cell lines it was highly toxic. 
Interestingly Huth et al. showed that the effects of chlorpromazine on uptake of liposomes was cell 
line dependent and that it enhanced liposome uptake in COS-7 cells [47]. In agreement with this we 
show cell line specific inhibition of hTf uptake at the tested concentrations of chlorpromazine; only 
in D407 cells we did observe the expected effects. Moreover, to the best of our knowledge this is 
the first demonstration of the effects of chlorpromazine on CIE, as chlorpromazine promoted 
noticeably the uptake of LacCer in ARPE-19, HuH-7 cells but also in Vero and COS-7 cells when 
applying higher chlorpromazine concentrations (data not shown). It may be the case that inhibition 
of clathrin coated uptake may upregulate other pathways and we are currently pursuing this line of 
observation. Alternatively, because of the short timeframe wherein these compensatory 
mechanisms should occur, it could be, as described, that this amphipathic molecule is affecting the 
fluidity of the membrane in a positive way and therefore facilitating endocytosis [27]. Furthermore, 
despite the fact that ARPE-19 and D407 cells are both model cell lines for human retinal pigment 
epithelial cells, the effects of nearly all inhibitors differ strongly on these related cell lines. The 
same cell dependency can likely explain why our results on the inhibition of LacCer uptake by 
potassium depletion and chlorpromazine differ to some extent with the results obtained by Puri et 
al. in skin fibroblasts [13]. 
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We also compared two different approaches to evaluate the inhibition of uptake of the two 
endocytic probes. We qualitatively estimated the inhibitory effects on CLSM images and we 
quantitatively assessed internalization of biomarker by flow cytometry. The latter method has the 
advantage of being a relatively easy to use method to quantitatively describe the inhibitory effect 
by analyzing a large population of cells (50,000 in our study). While flow cytometry integrates the 
total fluorescence per cell, CLSM gives a visual presentation of what the intracellular fluorescence 
pattern looks like at the single cell level. CLSM images, therefore, give complementary 
information to the flow cytometry data. When we compared the effects of potassium depletion on 
hTf uptake in ARPE-19 and D407 cells by CLSM we observed a similar intracellular distribution 
(i.e. an enrichment in the perinuclear region) of the labeled hTf in the absence of potassium 
depletion. However, very different profiles were observed in the potassium depleted cells where in 
ARPE-19 cells the label was scattered throughout the cytosol and in D407 cells it was constrained 
to the plasma membrane. This confirmed the flow cytometry data where the plasma membrane 
fraction of transferrin in D407 cells is lost by acid washing and thus, in these cells, the amount of 
internalized label was very low in K+-depleted cells. Despite the fact that potassium depletion did 
not affect the uptake of transferrin in three of the five cell lines it has a significant effect 
downstream of the plasma membrane, possibly by inhibiting its traffic to recycling compartments. 
Thus valuable endocytic information can be gained by combining microscopy and flow cytometry 
analysis. Nonetheless, care should be taken when drawing conclusions on inhibitory effects of 
inhibitors, solely based on confocal images; first of all it is important that laser intensities and 
detector sensitivities should be identical when comparing images. Secondly, since only a limited 
number of cells are usually observed in microscopy images, interpretation might be biased if the 
inhibitor effect is heterogeneous (see for example Fig. 6b). 
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While it is clear that endocytosis inhibitors should be used with care, there is scope for their 
continued use for unravelling the uptake mechanisms of endocytic probes for cell biology and drug 
or gene delivery systems, especially when different methods are combined. New and more specific 
endocytosis inhibitors are urgently required and there is an equal need for new specific biomarkers, 
which associate specifically with certain endocytic pathways or vesicles. But as is often the case, a 
particular protein may be involved in a number of uptake mechanisms (e.g. dynamin) or be 
required for traffic at several cell locations (e.g. clathrin). Undoubtedly the combination of 
inhibitors and biological strategies to specifically inhibit endocytosis (e.g. RNAi or transfection of 
dominant negative proteins) will provide more information. This however is reliant on being able to 
silence a protein without affecting cell viability and other endocytic pathways and identifying a 
suitable probe whose access is constrained to one pathway.  
 
CONCLUSION 
 
In this work we have given additional experimental evidence to highlight the care needed in 
the interpretation of data obtained from using chemical inhibitors of endocytosis. We have found 
that the inhibitory effect is extremely cell type dependent, as is the concentration for minimizing 
cellular toxicity and maximizing inhibitory effect. Moreover, chemical compounds can produce 
pronounced side effects on cellular morphology and the inhibition is not always as specific for a 
particular endocytic pathway as is sometimes stated in literature. We conclude that treatment with 
endocytosis inhibitors, which have been applied successfully on one cell line, should not be blindly 
transferred to other cell lines without performing the necessary control experiments. Additionally, 
combining the use of chemical inhibitors with inhibition of specific pathways through siRNA 
silencing or the expression of dominant negative proteins is likely to give more meaningful data. 
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This in turn can be complemented by fluorescence microscopy experiments using fluorescently 
labeled gene complexes and fluorescent tracers that are specific for certain endocytic pathways. 
The combined results may ultimately provide important information on the mechanisms by which 
non-viral gene vectors enter cells. 
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MATERIALS AND METHODS 
 
Materials 
 
Chlorpromazine, MßCD, genistein and lovastatin (mevinolin) were purchased from Sigma 
Aldrich (Bornem, Belgium). Propidium iodide (PI) solution was from Invitrogen (Merelbeke, 
Belgium). Dulbecco's modified Eagle's medium (DMEM), OptiMEM, L-glutamine (L-Gln), foetal 
bovine serum (FBS), penicillin-streptomycin (5000 IU/ml penicillin and 5000 µg/ml streptomycin) 
(P/S) and phosphate buffered saline (PBS) were supplied by GibcoBRL (Merelbeke, Belgium). 
Human transferrin-AlexaFluor633 (hTF) and bovine serum albumin (BSA)-complexed BODIPY 
FL C5
 
-lactosylceramide (LacCer) were purchased from Molecular Probes (Merelbeke, Belgium). 
BODIPY-labeled LacCer was applied to the cells as a complex with BSA, which makes the lipid 
marker water soluble and therefore presentable to cells [13]. 
Cell culture 
 
COS-7 cells (African green monkey kidney fibroblast cell line; ATCC number CRL-1651) 
and Vero cells (African green monkey kidney epithelial cell line; ATCC number CCL-81) were 
cultured in DMEM containing 10 % FBS, 2 mM L-Gln and 2 % P/S. HuH-7 cells (human 
hepatocellular carcinoma cell line; HSRRB number JCRB 0403) and ARPE-19 cells (retinal 
pigment epithelial cell line; ATCC number CRL-2302) were cultured in DMEM:F12 supplemented 
with 10 % FBS, 2 mM L-Gln and 2 % P/S. D407 (retinal pigment epithelial cell line) cells [48] 
were a kind gift from Dr Richard Hunt (University of South Carolina, Medical School, Columbia, 
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USA) and were cultured in DMEM with high glucose concentration (4500 mg/l), 5 % FBS, 2 mM 
L-Gln and 2 % P/S. All cells were grown at 37°C in a humidified atmosphere containing 5 % CO2
 
. 
Cytotoxicity analysis 
 
The cytotoxicity of the different inhibition protocols was evaluated using the EZ4U cell 
proliferation and cytotoxicity assay kit (Biomedica, Vienna, Austria). This assay is based on the 
principle of the classical MTT test where tetrazolium salts are reduced into intensely coloured 
formazan derivatives by mitochondrial enzymes which are rapidly inactivated within a few minutes 
after cell death. The assay was performed according to the manufacturer’s instructions. Briefly, 
cells were seeded at 105 cells/well in a 24-well plate for 24 h. They were then incubated in 
OptiMEM with various concentrations of the described inhibitors for 2 h. For potassium depletion, 
cells were washed twice with potassium depletion buffer (140 mM NaCl, 20 mM Hepes, 1 mM 
CaCl2, 1 mM MgCl2, 1 mg/ml D-glucose, pH 7.4), then incubated for 15 min with hypotonic 
buffer (1:1 potassium depletion buffer and H2
 
O) at 37°C and finally washed again 3 times with 
potassium-free buffer. Subsequently, the cells were immediately incubated with the EZ4U substrate 
(40 µl substrate with 260 µl culture medium per well) containing the tetrazolium salts. After 3 h at 
37°C, the absorbance of the coloured formazan was measured on a Wallac Victor Plate reader 
(Perkin Elmer-Cetus Life Sciences, Boston, MA, USA) at 460 nm and corrected for the absorbance 
measured at 630 nm which represents nonspecific absorbance.  
Inhibition and specificity studies 
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For inhibition and specificity studies, enough cells were seeded on sterile MatTek coverslip 
(1.5)-bottom dishes (MatTek corporation, MA, USA) (for confocal analysis) or 6-well plates (for 
flow cytometry analysis) to reach 70 % confluency 24 h later. The cells were subsequently 
incubated with the indicated concentration of inhibitor in OptiMEM for the appropriate time. For 
potassium depletion, cells were processed as described above in potassium-free and hypotonic 
buffer. The cells were then incubated with 16,7 µg/ml hTf or 0.81 µM LacCer for 15 min at 37°C 
in the presence of the relevant inhibitor or buffer. hTF and LacCer uptake under different 
conditions were then qualitatively and quantitatively evaluated using confocal laser scanning 
microscopy (CLSM) and flow cytometry. 
 
Confocal laser scanning microscopy (CLSM) 
 
The internalisation of the fluorescently tagged biomarkers hTF and LacCer was visualized 
and evaluated with a Nikon C1 confocal laser scanning microscope (Nikon Belux, Brussels, 
Belgium) equipped with a Plan Apo VC 60x 1.4 NA oil immersion objective lens and suitable 
optical elements to obtain fluorescent and differential interference contrast (DIC) transmission 
images. Bodipy FL labeled LacCer was excited with the Argon ion 488 nm laser line and emission 
light was collected using a 500-530 nm band pass filter. AlexaFluor 633 labeled hTF was excited 
with the diode 639 nm laser line and emission light was collected using a 655 nm long pass filter. 
After removing the medium with the marker and inhibitor, cells were imaged in HMEM-G+I 
(DMEM without glucose (GibcoBRL Merelbeke, Belgium) with 5 mM NaN3, buffered with 10 
mM HEPES to a pH of 7.4 to deplete the cells of energy by inhibiting mitochondrial respiration 
[49]. Representative 2D confocal images were acquired approximately through the middle plane of 
the cell.  
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Flow cytometry analysis 
 
Prior to measuring the cell-associated fluorescence with flow cytometry, it is imperative to 
remove the fraction of fluorescently labeled markers, hTf and LacCer, that are associated with the 
plasma membrane but not internalized. For transferrin a well established acid wash step was used 
for this purpose [50]. Following incubation with the marker for 15 min, the cells were washed 
twice with cold HMEM-G+I to inhibit metabolic activities followed by 1 min incubation in ice cold 
acid wash buffer (0,2 M acetic acid and 0,2 M NaCl). The cells were then quickly washed twice 
with ice cold HMEM-G+I. For LacCer, surface associated fluorescent lipid is extracted out of the 
plasma membrane (back exchange [15]) by adding defatted BSA. This will only have access to 
plasma membrane localized fluorescent lipid and not the fraction that is internalized. After 
incubation with LacCer, the cells were washed twice with cold HMEM-G+I. and then washed 6 
times for 10 min with cold HMEM-G+I supplemented with 5% defatted BSA. After the removal of 
non-internalized fluorescent markers, the cells were finally detached with trypsin and EDTA, 
centrifuged and resuspended in ice cold flow buffer (1 % BSA and 0,1 % NaN3
For quantification, the experiments were performed in triplicate and for each sample 50,000 
events were collected by list-mode data that consisted of side scatter, forward scatter and 
fluorescence emission centered at 530 nm (FL1, for AF488 and Bodipy FL) and 620 nm (FL3, for 
PI)). CXP software (Beckman Coulter, Nyon, Switzerland) was used for the analyses. The data 
 in PBS). The 
remaining (internal) fluorescence of the cells was analyzed with a 5-color FC500 flow cytometer 
(Beckman Coulter, Nyon, Switzerland) equipped with an argon laser (excitation at 488 nm). To 
stain dead cells, PI stock solution was diluted till 10 µg/ml in the cell suspension, 1 min before 
analysis, to stain nuclei of (dead) cells with a permeated plasma membrane. 
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were generated from ungated cells. The internalization of fluorescent marker is calculated as the 
mean fluorescence value (average of three experiments) corrected for a 0% uptake and normalized 
to a 100% uptake. The 0% uptake was determined from cells at 4°C which have been incubated 
with the marker for 15 min and underwent the same acid wash or back exchange. The 100% uptake 
was determined from cells which have not been exposed to any inhibitor and have been incubated 
with the marker for 15 min followed by an acid wash or back exchange as described above.  
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SUPPLEMENTAL MATERIAL 
 
Figure S1. Schematic presentation of a current classification of the endocytic mechanisms in 
mammalian cells. Proposed classification system for the endocytic mechanisms in mammalian 
cells. Endocytosis can be divided as phagocytosis and pinocytosis, but because phagocytosis is 
restricted to specialized cells, endocytosis and pinocytosis are often used as synonyms. Pinocytosis 
represents macropinocytosis, clathrin dependent endocytosis (CDE) and clathrin independent 
endocytosis (CIE). 
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FIGURE LEGENDS 
 
Figure 1. In vitro cytotoxicity of inhibitors. In vitro viability of D407, Vero, COS-7, HuH-7 and 
ARPE-19 cells incubated for 2 hr with endocytosis inhibitors (a) chlorpromazine, (b) K+
 
-depletion 
buffer, (c) MßCD and (d) genistein. Cell viability was assessed with an MTT based assay. Values 
are given as means + SD of quadruplicates. 
Figure 2. Optimization of the concentration of MßCD to inhibit CIE in D407 cells. 
Optimization of the concentration of MßCD to inhibit CIE in D407 cells. Cells were incubated with 
LacCer (green) following preincubation with increasing concentrations of MßCD for different 
incubation times. (a) positive control (b) 30 min 2.5 mM MßCD (c) 1 h 2.5 mM MßCD (d) 2 h 3 
mM MßCD (e) 2 hr 5 mM MßCD and (f) 2 h 10 mM MßCD. The presence of fluorescently labeled 
vesicles in the interior of the cell is a measure of endocytic uptake of LacCer. Arrows are pointing 
out cells which suffered the MßCD treatment, resulting in rounding up and lifting of the cells from 
the growth surface. All experiments were performed at least 3 times and representative images are 
shown. Scalebars = 20 µm. 
 
Figure 3. Effect of chlorpromazine on morphology of Vero cells. The diagram shows side and 
forward scattering histograms for Vero cells as measured by flow cytometry. In the scatterplots, 
each spot represents a cell and the X- and Y-values are related with size (forward scatter) and 
granularity (side scatter). Scatterplot of (a) normal untreated Vero cells, (b) Vero cells treated for 2 
h with 10 µg/ml chlorpromazine and stained for dead cells with PI (c) Vero cells treated with 
chlorpromazine and incubated with LacCer and back exchanged with defatted BSA prior to PI 
staining. The percentage of PI positive cells is shown in the right lower corner of the diagrams.  
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Figure 4. Efficacy of endocytosis inhibitors. Quantification of hTF (a) and LacCer (b) uptake by 
flow cytometry in ARPE-19, Vero, D407, COS-7 and HuH-7 cells after incubation with (a) 
chlorpromazine or potassium depletion buffer and (b) genistein or MßCD. Values are given as 
means + SD of triplicates.  
 
Figure 5. Intracellular distribution of LacCer after genistein treatment is dependent on cell 
type. Evaluation of LacCer uptake (green) in Vero (a and f), COS-7 (b and g), ARPE-19 (c and h), 
HuH-7 (d and i) and D407 (e and j) cells in the absence and presence of genistein. a - e control, f - 
j are the corresponding cell lines incubated with 400 µM genistein for 2 h. The amount of 
intracellular stained vesicles is a measure for the remaining uptake of LacCer (arrowheads). The 
percentage of remaining LacCer uptake shown at the bottom of the figure are the corresponding 
values obtained by flow cytometry. All experiments were performed at least 3 times and 
representative images are shown. Scalebars = 20 µm. 
 
Figure 6. Distribution of fluorescence values after marker uptake as obtained with FC. (a) 
Fluorescence intensity histograms of HuH-7 cells incubated with LacCer at 4°C (blue; “0 % 
uptake”), at 37°C (red; “100 % uptake”) and cells incubated with 400 µM genistein for 2 h prior to 
LacCer addition (green; “+ Genistein”). (b) Fluorescence intensity histograms of D407 cells 
incubated with hTF at 4°C (blue; “0 % uptake”), at 37°C (red; “100 % uptake”) and cells incubated 
with 400 µM genistein for 2 h prior to hTf addition (green; “+ Genistein”).  
 
Figure 7. Specificity of endocytosis inhibitors. Quantification of LacCer (a) and hTf (b) uptake 
by flow cytometry in ARPE-19, Vero, RPE (D407), COS-7 and HuH-7 cells after incubation with 
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(a) chlorpromazine or potassium depletion buffer and (b) genistein and MßCD. Values are given as 
means + SD of triplicates.  
 
Figure 8. Intracellular distribution of endocytic markers after K+-depletion in RPE cells. 
Evaluation by confocal microscopy of hTF (red) and LacCer (green) uptake in ARPE-19 (a-d) and 
D407 (e - h) cells. (a, e) control samples following incubation with hTf uptake, or (c, g) LacCer. 
(b, f, d, h) are the corresponding cell lines following K+
 
-depletion. All experiments were 
performed at least 3 times and representative images are shown. Scalebars = 20 µm. 
